Results

Looking for more? ProQuest® Dissertations & Theses has additional dissertations and theses.
15316 open access dissertations and theses found for:
if(Drug metabolizing enzymes)  »   Refine Search
1.
Changes in hepatic drug metabolizing enzymes during pregnancy
by Walker, Alysa, Ph.D.  University of Washington. 2010: 108 pages; 3424284.
2.
Phytochemical Investigation and Drug Interaction Potential of Cyanotis vaga
by Almarabi, Ibrahim Amer, M.S.  The University of Mississippi. 2019: 70 pages; 13879283.
3.
Microrna Regulation of the UGT2 Sub-family of Detoxifying Enzymes
by Sutliff, Aimee Kristina, Ph.D.  Washington State University. 2019: 171 pages; 13806406.
4.
Altered UDP-glucuronosyltransferase regulation and expression: Implications for cancer cell proliferation and drug treatment
by Dates, Centdrika Renee', Ph.D.  University of Arkansas for Medical Sciences. 2015: 147 pages; 3703979.
5.
The role of transporters in the absorption, distribution, metabolism and excretion (ADME) of orally administered drugs
by Shugarts, Sarah B., Ph.D.  University of California, San Francisco. 2010: 252 pages; 3390104.
6.
Characterization and Pharmacogenetics of Hepatic Phase I Exemestane Metabolism
by Peterson, Amity, Ph.D.  Washington State University. 2017: 160 pages; 10266284.
7.
Inhibition of cytochrome P450 enzymes by fruit juices: In vitro effects, clinical relevance, and therapeutic implications
by Hanley, Michael J., Ph.D.  Sackler School of Graduate Biomedical Sciences (Tufts University). 2012: 237 pages; 3548301.
9.
The effect of the dynamic interplay of P-glycoprotein and cytochrome P450 3A on the portal bioavailability of dual substrates
by Dufek, Matthew Beau, Ph.D.  The University of North Carolina at Chapel Hill. 2011: 207 pages; 3465198.
10.
Inhibition and absolute quantitation of human aldehyde oxidase
by Barr, John Thomas, Ph.D.  Washington State University. 2013: 129 pages; 3611243.
11.
Hepatic stress response mechanisms in progressive human nonalcoholic fatty liver disease
by Lake, April D., Ph.D.  The University of Arizona. 2013: 271 pages; 3590010.
12.
Physiologic effects of cytochrome P450 3A activity
by Givens, Raymond Carlos, Ph.D.  The University of North Carolina at Chapel Hill. 2007: 127 pages; 3289052.
13.
The Intricacies of UGT Regulation: Protein-Protein Interactions and Environmental Arsenic Exposure
by Konopnicki, Camille Maria, Ph.D.  University of California, San Diego. 2012: 237 pages; 3549057.
14.
The structural bases of stability-function tradeoffs inantibiotic resistance enzymes
by Thomas, Veena Lily, Ph.D.  University of California, San Francisco. 2009: 162 pages; 3390102.
15.
Elucidating warfarin metabolic pathways and developing novel analytical methods paves the way for improving clinical care
by Jones, Drew Rondall Eugene Willie, Ph.D.  University of Arkansas for Medical Sciences. 2011: 190 pages; 3454562.
16.
How Quantitative Clinical Pharmacology Can Bring Value to the Patient
by Mangal, Naveen, Ph.D.  University of Florida. 2017: 159 pages; 13847474.
17.
Impact of Cellular Retinol Binding Protein, Type I on Retinoic Acid Biosynthesis and Homeostasis
by Pierzchalski, Keely A., Ph.D.  University of Maryland, Baltimore. 2015: 190 pages; 3704610.
18.
SULT1A1 Genetic Variation and Tamoxifen Response in Vitro and ex Vivo
by Daniels, Jaclyn Rochelle, Ph.D.  University of Arkansas for Medical Sciences. 2015: 140 pages; 10103541.
19.
22.
In vitro thyroid hormone metabolism: Effects of nuclear receptor activation on the metabolic profiles of thyroxine in rat and human hepatocytes
by Richardson, Vicki Michele, Ph.D.  The University of North Carolina at Chapel Hill. 2013: 225 pages; 3562945.
25.
Metabolizing birth: The impact of labor and birth on the maternal mind
by Williams, Jacqueline, Ph.D.  Pacifica Graduate Institute. 2016: 147 pages; 10140839.
26.
Mapping drug chemistry from the viewpoint of small molecule metabolism
by Adams, James Corey, Ph.D.  University of California, San Francisco. 2009: 107 pages; 3359572.
27.
Drug Target Discovery Using Designer Drug Sensitive Yeast
by Goldgof, Gregory Mark, Ph.D.  University of California, San Diego. 2017: 183 pages; 10234614.
28.
Targeting the brain: Identifying and inhibiting harmful protein-amyloid interactions in Alzheimer's disease
by Habib, Lila K., Ph.D.  University of California, San Diego. 2011: 149 pages; 3481934.
29.
Regulation of Pregnane X Receptor by Post-translational Modification
by Pasquel, Danielle R., Ph.D.  Yeshiva University. 2015: 205 pages; 10019210.
30.
Untangling the interactions: Structural basis of nitric oxide regulated cyclic-di-GMP metabolism in bacteria
by Lahiri, Tanaya, Ph.D.  State University of New York at Stony Brook. 2013: 152 pages; 3608293.
1 - 30 of 15316 displayed.
  1    2    3    4    5    6    7    8    9    10    11   Next >
Copyright © 2020 ProQuest LLC. All rights reserved. Terms and Conditions Privacy Policy Cookie Policy
ProQuest